Status unknownNCT01114867Updated Mar 27, 2014

Fetal Penile Length and Corpus Cavernosum Length - Normal Measurement Via Ultrasound

An observational study in Fetal Penis Length, sponsored by Tel-Aviv Sourasky Medical Center. Status unknown at 1 site in Israel. Open to male participants aged 14 Weeks to 34 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-03-27.

Sponsored by Tel-Aviv Sourasky Medical Center · Observational

The sponsor has not verified this record recently (last verified Apr 2010), so the status shown — last known as Not yet recruiting — may be out of date.

Study type: Observational
Model: Case-control
Time perspective: Prospective
Enrollment: 200
Ages: 14 Weeks to 34 Weeks
Sex: Male

Study summary

Hypothesis: Measurement of fetal penis length by ultrasound may be inaccurate when measured from the scrotum to the penile tip. we will provide normal values of penile length measured from the penile tip to the abdominal wall and measuring the corpus cavernosum length.

Conditions studied

Fetal Penis Length

Keywords

ultrasound
penis length
corpus cavernosum
length of fetal penis and fetal corpus cavernosum

In context

Lead sponsor

Tel-Aviv Sourasky Medical Center is the lead sponsor of 541 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 14 Weeks to 34 Weeks
Sexes eligible: Male
Accepts healthy volunteers: Yes
Sampling method: Non-probability sample

Study population

Fetuses of healthy pregnant women

Inclusion criteria

pregnant women at 14th through 34th week gestation,
routine ultrasound not preformed for anomalies at the genitourinary system,
estimated fetal weight corresponds to gestational age.

Exclusion criteria

Exclusion Criteria:

women who's fetuses are suspected to be with fetal growth retardation,
women who's fetuses are suspected to be with genitourinary anomaly.

Study design

Observational model: Case-control
Time perspective: Prospective
Enrollment: 200 participants (estimated)

Study locations

1 site

Ultrasound Unit in OBGYN, Soraski Medical Center
Tel-Aviv, 64239, Israel
- Yoseph Hartoov, Dr · Contact · +972-3-6925747
- Arnon Agmon, Dr · Contact · arnon@arnonagmon.com · +972-3-6925747
- Yoseph Hartoov, Dr · Principal investigator

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Mar 27, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT01114867
Lead sponsor: Tel-Aviv Sourasky Medical Center
First posted: May 3, 2010
Start date: Oct 2010
Last update: Mar 27, 2014

Study contacts

Yoseph Hartoov, Dr

principal investigator · Tel-Aviv, Soraski Medical Center

Oversight

Data monitoring committee: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Tel-Aviv Sourasky Medical Center

Start the discussion